IP Library Granted Patent US 11,572,592
Granted Patent B2
US 11,572,592 · App. 17/222,484 · Granted Feb 7, 2023

Labelling compounds and their use in assays

Inventors: Barrie J. Marsh (Trowbridge, GB); Christopher G. Frost (Trowbridge, GB); Jonathan Sharp (Trowbridge, GB)
Assignee: Binx Health Limited
C12Q1/689C07F15/02C07F17/02C12Q1/6816G01N27/3276G01N33/58C12Q2563/113
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,572,592
App. No.
17/222,484
Granted
Feb 7, 2023
Kind
B2
Abstract

The invention provides monoferrocenyl compounds of general formula I. The invention also provides substrates labelled with the compounds, functionalised derivatives of the compounds and methods of using the compounds, functionalised derivatives and labelled substrates in electrochemical assays.

Claims (16)

1. A compound of formula III:

wherein:

each X substituent is independently selected from halo, vinyl, alkyl, cycloalkyl, SiR 3 , SnR 3 , PR 2 , P(O)R 2 , SR, S(O)R, SO 2 R, aryl, heteroaryl, CHO, CO 2 R, CN and CF 3 ;

each R is independently selected from alkyl, cycloalkyl, aryl and heteroaryl;

Y is CH 2 and Z is (CH 2 ) 3 ;

[S] is a nucleic acid; and

L′ is a phosphoramidite linkage to the nucleic acid,

wherein a is 1, 2, 3 or 4 and b is 0, 1, 2, 3, 4 or 5, and

wherein any vinyl, alkyl, cycloalkyl, alkylene, aryl and heteroaryl may optionally be substituted with 1, 2 or 3 substituents independently selected from unsubstituted alkyl, OH, CN, fluorine, chlorine, bromine and iodine.

2. The compound of claim 1 , wherein nucleic acid has a sequence which is complementary to a sequence in a microorganism selected from the group consisting of Chlamydia trachomatis, Trichomonas vaginalis, Neisseria gonorrhoeae, Mycoplasma genitalium and methicillin resistant Staphylococcus aureus.

3. The compound of claim 1 , wherein X is alkyl.

4. The compound of claim 1 , wherein Y is alkyl.

5. The compound of claim 1 , wherein X is methyl.

6. The compound of claim 1 , wherein a is 4.

7. The compound of claim 1 , wherein b is 5.

8. The compound of claim 1 , wherein the nucleic acid is an oligonucleotide designed to detect a specific gene.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2022
From: MARSH, BARRIE J.; FROST, CHRISTOPHER G.; SHARP, JONATHAN
To: ATLAS GENETICS LIMITED
Reel/Frame 058892/0109 →
CHANGE OF NAME Recorded Feb 4, 2022
From: ATLAS GENETICS LIMITED
To: BINX HEALTH LIMITED
Reel/Frame 058892/0125 →
Continuity (3)
Division 15783130 · Oct 13, 2017
Continuation 15026454
Related Publication 20220025440A1 · Jan 27, 2022